Glucose-6-Phosphate Dehydrogenase Modulates Cytosolic Redox Status and Contractile Phenotype in Adult Cardiomyocytes
- 25 July 2003
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 93 (2) , e9-16
- https://doi.org/10.1161/01.res.0000083489.83704.76
Abstract
Reactive oxygen species (ROS)–mediated cell injury contributes to the pathophysiology of cardiovascular disease and myocardial dysfunction. Protection against ROS requires maintenance of endogenous thiol pools, most importantly, reduced glutathione (GSH), by NADPH. In cardiomyocytes, GSH resides in two separate cellular compartments: the mitochondria and cytosol. Although mitochondrial GSH is maintained largely by transhydrogenase and isocitrate dehydrogenase, the mechanisms responsible for sustaining cytosolic GSH remain unclear. Glucose-6-phosphate dehydrogenase (G6PD) functions as the first and rate-limiting enzyme in the pentose phosphate pathway, responsible for the generation of NADPH in a reaction coupled to the de novo production of cellular ribose. We hypothesized that G6PD is required to maintain cytosolic GSH levels and protect against ROS injury in cardiomyocytes. We found that in adult cardiomyocytes, G6PD activity is rapidly increased in response to cellular oxidative stress, with translocation of G6PD to the cell membrane. Furthermore, inhibition of G6PD depletes cytosolic GSH levels and subsequently results in cardiomyocyte contractile dysfunction through dysregulation of calcium homeostasis. Cardiomyocyte dysfunction was reversed through treatment with either a thiol-repleting agent (L-2-oxothiazolidine-4-carboxylic acid) or antioxidant treatment (Eukarion-134), but not with exogenous ribose. Finally, in a murine model of G6PD deficiency, we demonstrate the development of in vivo adverse structural remodeling and impaired contractile function over time. We, therefore, conclude that G6PD is a critical cytosolic antioxidant enzyme, essential for maintenance of cytosolic redox status in adult cardiomyocytes. Deficiency of G6PD may contribute to cardiac dysfunction through increased susceptibility to free radical injury and impairment of intracellular calcium transport. The full text of this article is available online at http://www.circresaha.org.Keywords
This publication has 39 references indexed in Scilit:
- Glucose-6-Phosphate Dehydrogenase Overexpression Decreases Endothelial Cell Oxidant Stress and Increases Bioavailable Nitric OxideArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- Control of Mitochondrial Redox Balance and Cellular Defense against Oxidative Damage by Mitochondrial NADP+-dependent Isocitrate DehydrogenaseJournal of Biological Chemistry, 2001
- Redox Regulation of Cardiomyocyte Survival and DeathAntioxidants and Redox Signaling, 2001
- Impaired Cell Shortening and Relengthening with Increased Pacing Frequency are Intrinsic to the Senescent Mouse CardiomyocyteJournal of Molecular and Cellular Cardiology, 2000
- Ribose-enhanced Synthesis of UTP, CTP, and GTP from Parent Nucleosides in Cardiac MyocytesJournal of Molecular and Cellular Cardiology, 1998
- A glucose-6-phosphate dehydrogenase (G6PD) splice site consensus sequence mutation associated with G6PD enzyme deficiencyMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1997
- Cellular reducing equivalents and oxidative stressFree Radical Biology & Medicine, 1994
- Study of glucose‐6‐phosphate dehydrogenase: History and molecular biologyAmerican Journal of Hematology, 1993
- Rapid stimulation of the hexose monophosphate shunt in the isolated perfused rat heart: Possible involvement of oxidized glutathioneJournal of Molecular and Cellular Cardiology, 1981
- Isozymes of isocitrate dehydrogenase: Subunit structure and intracellular locationJournal of Experimental Zoology, 1965